JD health has offered 381.9 million shares in the Hong Kong IPO at a price range of HK $62.8-70.58.

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

EqualOcean and Skepsos Sign Strategic Cooperation Memorandum of Understanding

On May 20, 2025, Beijing EO Technology Co.,Ltd and the Greater Paris Health Industry Park (Skepsos) officially signed a Memorandum of Understanding on Strategic Cooperation in Beijing.

Trump Launches "Section 232 Investigations" into Semiconductors and Pharmaceuticals

Capital Frenzy: AI Healthcare's Inflection Point

Is AI healthcare now approaching its own “DeepSeek Moment” as it rides a new wave of momentum?

China's First Modified New Drug of Docetaxel Successfully Went to the US